Article

Hip Instability Progresses Most Rapidly in Patients With SMA Type 1

Author(s):

By the age of 4 years, all children with type 1 SMA included in the study had subluxated hips.

Hip instability is prevalent across all types of spinal muscular atrophy (SMA), although it occurs most rapidly in SMA type 1, according to a new study abstract appearing in Developmental Medicine & Child Neurology for the American Academy for Cerebral Palsy and Developmental Medicine conference, which took place September 23-26, 2020.

Previous research has made it known that hip subluxation and dislocation are often observed in children with SMA, although medical complexity and an expected shortened life span has led to absence of monitoring and subsequent intervention for pathologic hips, according to the researchers of the study.

“However, recent advancements in therapies have resulted in prolonged life expectancy and increased function and mobility in children with SMA, thus making orthopedic function an important consideration,” they noted. “Since the rates of pattern of hip migration and acetabular morphology in SMA have not been well described, this study examines the progression of hip instability across all types of SMA in a pediatric population.”

The study included 45 children with SMA: 6 had type 1, 25 had type 2, and 14 had type 3. All x-rays taken of patients before the age of 18 years were measured for Reimer’s migration index (MI), acetabular depth ratio (ADR), and acetabular index (AI).

By the age of 4 years, all children with type 1 SMA had subluxated hips. Also by the age of 4 years, MI values were difference from one another across all 3 SMA subtypes.

All 3 subtypes experienced decreases in ADR with age, which is in contrast with the trend observed among unaffected patients. According to the researchers, ADR regression lines were negative and statistically significant between the 3 groups. They also observed that that AI values were higher for all 3 types of SMA, which contrasts from that seen in normal hips.

“Future research is needed to understand how hip morphology in children with SMA is affected by currently available and developing gene therapies or other treatments, in order to help guide modern treatment decisions such as optimal surgical timing and technique,” wrote the researchers, reflecting on their findings.

Reference

Coomer W, Gerk A, Kwok C, et al. Progression of hip instability in children with spinal muscular atrophy. 2020;62(3):4-134.

Related Videos
Vamshi Rao, MD
Vamshi Rao, MD
Vamshi Rao, MD
Vamshi Rao, MD
Vamshi Rao, MD
Jill Jarecki, PhD, chief scientific officer at Cure SMA
Jill Jarecki, PhD, chief scientific officer at Cure SMA
Mary Schroth, MD, FAAP, FCCP, chief medical officer at Cure SMA.
Jill Jarecki, PhD, chief scientific officer at Cure SMA and research director of TREAT-NMD Neuromuscular Network
Mary Schroth, MD, FAAP, FCCP, chief medical officer at Cure SMA
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo